Browse: Departments Dates Agencies
SUBJECT CATEGORY: New Animal Drugs for Use in Animal Feeds; Monensin and Tylosin
DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for use of monensin and tylosin singleingredient Type A medicated articles to make combination drug Type C medicated feeds used for improved feed efficiency, prevention and control of coccidiosis, and reduction of the incidence of liver abscesses in cattle fed in confinement for slaughter.
SUMMARY: Monensin and tylosin,
In accordance with the freedom of information provisions of 21 CFR part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(2) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:
1. The authority citation for 21 CFR part 558 continues to read as follows:
Authority: 21 U.S.C. 360b, 371.
2. Section 558.355 is amended by adding paragraph (f)(3)(xii) to read as follows:
Sec. 558.355 Monensin.
* * * * *
(f) * * *
(3) * * *
(xii) Amount per ton. Monensin, 10 to 30 grams; plus tylosin, 8 to 10 grams.
(a) Indications for use. For improved feed efficiency, prevention
and control of coccidiosis due to Eimeria bovis and E. zuernii, and
reduction of incidence of liver abscesses caused by Fusobacterium necrophorum and Actinomyces (Corynebacterium) pyogenes.
(b) Limitations. Feed only to cattle being fed in confinement for
slaughter. Feed continuously to provide 50 to 360 milligrams monensin
per head per day. For prevention and control of coccidiosis, feed at a
rate of 0.14 to 0.42 milligram monensin per pound of body weight per
day, depending upon the severity of challenge, up to maximum of 360
milligrams per head per day; and 60 to 90 milligram of tylosin per head per day.
* * * * *
Dated: February 15, 2001.
Claire M. Lathers,
Director, Office of New Animal Drug Evaluation Center for Veterinary Medicine.
[FR Doc. 015219 Filed 3201; 8:45 am]
BILLING CODE 416001F
FOR FURTHER INFORMATION CONTACT Daniel A. Benz, Center for Veterinary Medicine (HFV126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 3018270223.
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 26 CFR Part 1 40 CFR Part 180 47 CFR Part 73 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 26 CFR Part 301 50 CFR Part 660 39 CFR Part 111 40 CFR Part 300 44 CFR Part 65 40 CFR Part 271 40 CFR Parts 52 and 81 47 CFR Part 64 50 CFR Part 665 49 CFR Part 571 44 CFR Part 64 21 CFR Part 522 50 CFR Part 229 14 CFR Part 23